EndoChoice Holdings Inc. (GI) Sets New 52-Week Low at $3.64
EndoChoice Holdings Inc. (NYSE:GI) shares reached a new 52-week low during mid-day trading on Friday . The stock traded as low as $3.64 and last traded at $3.67, with a volume of 65,952 shares changing hands. The stock had previously closed at $3.82.
Several research firms have recently issued reports on GI. Stifel Nicolaus lowered their price objective on EndoChoice Holdings from $10.00 to $7.00 and set a “buy” rating for the company in a research note on Thursday, August 4th. William Blair downgraded EndoChoice Holdings from an “outperform” rating to a “market perform” rating in a research note on Thursday, August 4th. JPMorgan Chase & Co. downgraded EndoChoice Holdings from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 4th. Finally, Zacks Investment Research downgraded EndoChoice Holdings from a “buy” rating to a “hold” rating in a research note on Wednesday, August 3rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $7.42.
The firm’s 50 day moving average price is $4.55 and its 200-day moving average price is $4.71. The stock’s market capitalization is $98.46 million.
EndoChoice Holdings (NYSE:GI) last posted its earnings results on Wednesday, August 3rd. The company reported ($0.99) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.52) by $0.47. The business earned $19.30 million during the quarter, compared to analyst estimates of $20.67 million. The firm’s quarterly revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the firm earned ($1.01) earnings per share. On average, analysts forecast that EndoChoice Holdings Inc. will post ($2.53) earnings per share for the current fiscal year.
Endochoice Holdings, Inc, formerly ECPM Holdings, LLC, is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.